Navigation Links
Frost & Sullivan Recognizes Kionix's Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Date:8/26/2008

vity, navigation-grade accelerometers as well as less-sensitive, consumer-grade products. These products have been widely accepted in game controllers, notebook computers, hard disk drives (HDD), and personal navigation devices. The KXSC7 now allows Kionix's customers entry into battery-operated applications that are sensitive to power consumption. It will allow end-users access to smaller devices, such as cell phones, that require the 3x3mm form factor instead of a 5x5mm form factor.

"The KXCS7 is not only an enhancement in its packaging, but represents an improvement in wafer fabrication as well," continues V. Sankaranarayanan. "Kionix's proprietary deep reactive ion etching technology, which distinguishes itself in its ability to create higher aspect ratios not attainable by others in the industry, enables the Company to create structures that others cannot."

The KXSC7 is an innovation of this unique sensor technology in parallel with its low-power application-specific integrated circuit (ASIC) design technology, which is an overall improvement in the Company's prior device fabrication. Additionally, although ASIC technologies for the industry are similar, Kionix's in-depth understanding of how sensor elements work to enable certain applications allows the Company to support its customers with the implementation of the device to achieve superior results. Devices are all individually tested and programmed to achieve the customer-specific requirements of offset voltage and performance.

Frost & Sullivan's research indicates that there currently exists a huge worldwide interest in MEMS accelerometers for gaming, mobile electronic devices, and numerous other applications. Kionix's timely introduction of the KXSC7 accelerometer, designed to address the requirements of the aforementioned markets, is expected to increase the Company's revenue growth. Hence, Kionix is the deserving recipient of the 2008 Frost & Sullivan Product Line Strategy Award in
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
2. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
3. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
4. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
5. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
6. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
7. Signalife Wins Second Frost & Sullivan Technology Award
8. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
9. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
10. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
11. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 DTS Language Services, ... Online Web Portal for Life Science organizations who need document ... the subject matter of their documents in advance with a ... reduce time-to-delivery of translations, often a critical factor in clinical ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... 14, 2014  3D Communications, a leading provider of strategic communications services ... media events in the United States and ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as Associate ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
...  Frank A. Critz, M.D., founder and medical director of Radiotherapy ... welcome this April when he returns to Fulton, Miss.  for ... will be April 14, 2012 at the Holiday Inn Express ... until 3 p.m., and lunch will be served. ...
... 20, 2012 The American College of Radiology (ACR) ... Donald P. Rosen, MD, chief executive officer of ACR ... research organization (CRO) and for-profit subsidiary of the ACR. ... of experience in radiology, including contract research and business ...
... Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm ... Virus (HIV) infections, announced today that it has ... pursuant to which the Company has agreed to ... stock at an aggregate purchase price of approximately ...
Cached Biology Technology:Radiotherapy Clinics of Georgia's Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award 2Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™ 2GeoVax Announces Private Placement of $2.2 Million 2GeoVax Announces Private Placement of $2.2 Million 3GeoVax Announces Private Placement of $2.2 Million 4
(Date:4/17/2014)... Calif. One day about eight years ago, ... California, Riverside, and her father were on a field trip ... upon an orchid they had never seen before. , Unable ... on orchids. The orchid turned out to be an ... Lophiaris silverarum . , "Lophiaris" is the genus name, ...
(Date:4/17/2014)... on a novel method to help kidney stone ... effective treatment possible., Kidney stones represent a major ... If left untreated, apart from being particularly painful, ... complications. In many patients treated successfully, stone recurrence ... pathological approach to diagnosis and treatment needs to ...
(Date:4/17/2014)... Gene expression is the process whereby the genetic ... products, such as proteins, which have numerous different ... as an important intermediary during gene expression, by ... molecular mechanisms involved in manufacturing proteins. , ... mRNA molecules present in an organism at a ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Rapid and accurate mRNA detection in plant tissues 2
... protein kinase is an essential regulator of cytoskeletal ... whether Rho kinase regulates microtubule remodeling or the ... remains unclear. By using the ROCK inhibitor, Y-27632, ... colleagues from First Affiliated Hospital of Jinan University ...
... know about MyPyramid the triangle depicting how many servings ... - but who knows about MyPlate - the circle showing ... 2011 by the United States Department of Agriculture (USDA) to ... a simple, colorful icon that prompts us to think about ...
... cell-based gene therapy holds promise for the treatment of devastating ... approach have been unclear. In a study online December 26th ... published by Cell Press, researchers evaluated a patient with a ... years after he had undergone a gene therapy procedure as ...
Cached Biology News:Who is using MyPlate? 2Gene therapy for human skin disease produces long-term benefits 2